Factor H binding to bone sialoprotein and osteopontin enables tumor cell evasion of complement-mediated attack.
about
Dentin matrix protein 1 enhances invasion potential of colon cancer cells by bridging matrix metalloproteinase-9 to integrins and CD44.Six genes expressed in bones and teeth encode the current members of the SIBLING family of proteinsThree SIBLINGs (small integrin-binding ligand, N-linked glycoproteins) enhance factor H's cofactor activity enabling MCP-like cellular evasion of complement-mediated attackOsteopontin and mucosal protectionBone sialoprotein and its transcriptional regulatory mechanismFurther evidence to support the melanocytic origin of MDA-MB-435Dmp1-deficient mice display severe defects in cartilage formation responsible for a chondrodysplasia-like phenotypeDevelopment of fragment-specific osteopontin antibodies and ELISA for quantification in human metastatic breast cancerEffect of Ca2+ ions on the adhesion and mechanical properties of adsorbed layers of human osteopontin.Mutations in factor H reduce binding affinity to C3b and heparin and surface attachment to endothelial cells in hemolytic uremic syndrome.Pregnancy-associated hemolytic uremic syndrome revisited in the era of complement gene mutations.Osteopontin: roles in implantation and placentation.Sustained conditional knockdown reveals intracellular bone sialoprotein as essential for breast cancer skeletal metastasis.Biochemical markers of bone turnover: part I: biochemistry and variabilityEngagement of myelomonocytic Siglecs by tumor-associated ligands modulates the innate immune response to cancerDownregulation of C3 and C4A/B complement factor fragments in plasma from patients with squamous cell carcinoma of the penis.Small integrin-binding ligand N-linked glycoproteins (SIBLINGs): multifunctional proteins in cancerBone sialoprotein mediates the tumor cell-targeted prometastatic activity of transforming growth factor beta in a mouse model of breast cancerThe role of complement in tumor growthComplement receptor 1 genetic variants contribute to the susceptibility to gastric cancer in chinese populationPrognostic significance of plasma osteopontin in patients with locoregionally advanced head and neck squamous cell carcinoma treated on TROG 02.02 phase III trial.Systems-level analysis of age-related macular degeneration reveals global biomarkers and phenotype-specific functional networks.Osteopontin Fragments with Intact Thrombin-Sensitive Site Circulate in Cervical Cancer PatientsBone sialoprotein binding to matrix metalloproteinase-2 alters enzyme inhibition kinetics.Structural requirements for bone sialoprotein binding and modulation of matrix metalloproteinase-2.Dentin matrix protein-1 isoforms promote differential cell attachment and migration.Is complement good or bad for cancer patients? A new perspective on an old dilemma.Immune and inflammatory pathways are involved in inherent bone marrow ossification.Complement factor H-derived short consensus repeat 18-20 enhanced complement-dependent cytotoxicity of ofatumumab on chronic lymphocytic leukemia cells.OPN-a induces muscle inflammation by increasing recruitment and activation of pro-inflammatory macrophages.Small integrin-binding proteins as serum markers for prostate cancer detectionBone sialoprotein and osteopontin in bone metastasis of osteotropic cancersFactor h: a complement regulator in health and disease, and a mediator of cellular interactions.Cancer intelligence acquired (CIA): tumor glycosylation and sialylation codes dismantling antitumor defense.Streptococcal beta protein has separate binding sites for human factor H and IgA-Fc.Recruitment of nuclear factor Y to the inverted CCAAT element (ICE) by c-Jun and E1A stimulates basal transcription of the bone sialoprotein gene in osteosarcoma cells.Temporal profiling and pulsed SILAC labeling identify novel secreted proteins during ex vivo osteoblast differentiation of human stromal stem cells.Differentially expressed genes in early gestational chorionic villi after administration of mifepristone.Overlapping functions of bone sialoprotein and pyrophosphate regulators in directing cementogenesis.Cancer Secretome May Influence BSP and DSP Expression in Human Salivary Gland Cells.
P2860
Q24538982-D2F0F620-69F0-40F9-9121-70D541FB316DQ28204658-137A35B7-B02A-4E5B-8EBF-96D5FEF3CF1EQ28217300-011A3128-835F-48B7-84D8-BA4CDDBB32C9Q28236080-22D89661-8D0F-44F8-B977-44888E2EDB79Q28270296-412C638E-09D7-4B7D-BDD4-49C6FD27169DQ30857872-4442958E-E60B-488D-B97B-554BC4C84748Q33209762-D52EA159-5F68-407A-9A28-C7488EC98784Q33317638-A27FEE35-319C-4FD9-8226-66F0E75749EFQ33347427-ACC2C1A8-5C21-468B-BA37-24357F3680CEQ33347509-42BC5064-9CC9-4618-8812-3BBF6B91395EQ33388474-90DD3BBA-5161-4616-9CCD-6E233252DABEQ34218572-A9544FE1-D8B7-48BB-9139-DD7A9E3AC439Q34221672-CDABBD77-54FC-4636-A467-368C3D2FD98DQ34239361-85CB3DCB-6B86-422B-AC6E-AF460732AB6EQ34314456-5836BB99-D9C6-4F62-8F79-3E984DAB4209Q34542887-8FE5F008-40AB-42F6-9BF8-57FA037DD61DQ34655823-11E97FD0-2A8B-4264-AEC5-9BFC74A3AB16Q34909724-4E378E9A-1564-4F16-8870-E0C8AEE23B61Q35231345-C03255A3-60C0-4D3A-ABFC-CF8AEDC4EA38Q35631618-4A39B46E-844A-48B1-8D7C-CCB0C6930019Q35652920-A4B71502-2B91-414E-BF9C-86DF41EFC169Q36023209-85CDA2C4-12AA-4716-BD1C-3E680E3B3D96Q36095801-D4C6D7E0-2D90-46E9-92D0-2F0F495769B1Q36791863-3C63C451-05BD-4531-A5E1-33C1908454B7Q36952540-98D44261-227C-42DA-8D14-912573DD2927Q36973689-0EDA14E5-B0D2-4012-B2EF-A150A1D96373Q37247425-7D3C13C4-BAE6-4535-A910-963313D2F77AQ37314069-B24482BB-58EF-4A86-A020-5A0D553259D0Q37377923-15DEB3FA-CEDC-4032-8589-82EF72D5C824Q37394133-2F168CC4-4091-4C2F-9156-5F0DAFA02ED0Q37397529-6B3FC383-98FB-4022-AD47-4430ADACFF52Q37625382-548BB06E-90DF-4F48-890C-314C2B3188BEQ38223669-37D5D294-F108-4DDC-B6C3-4F462F1EBDDDQ38285397-C6686187-1F26-489A-B4E3-217AAFF4796CQ38292615-FB125382-01C7-4E98-B952-2D29AA49288AQ38322398-8E9596AD-3741-4948-92F9-A9CC92B38B3AQ38323561-FB1DDB25-9EA3-4852-9A10-2C5841026241Q38506013-913C09E7-D044-40F8-AF7E-E2C25C17B8AAQ38693472-2AF175FE-810C-4D53-B792-7756AAE8B13DQ38729243-715722FF-DAEE-45C5-BCE1-1D2C71677FD2
P2860
Factor H binding to bone sialoprotein and osteopontin enables tumor cell evasion of complement-mediated attack.
description
2000 nî lūn-bûn
@nan
2000 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2000 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2000年の論文
@ja
2000年論文
@yue
2000年論文
@zh-hant
2000年論文
@zh-hk
2000年論文
@zh-mo
2000年論文
@zh-tw
2000年论文
@wuu
name
Factor H binding to bone sialo ...... of complement-mediated attack.
@ast
Factor H binding to bone sialo ...... of complement-mediated attack.
@en
type
label
Factor H binding to bone sialo ...... of complement-mediated attack.
@ast
Factor H binding to bone sialo ...... of complement-mediated attack.
@en
prefLabel
Factor H binding to bone sialo ...... of complement-mediated attack.
@ast
Factor H binding to bone sialo ...... of complement-mediated attack.
@en
P2093
P2860
P356
P1476
Factor H binding to bone sialo ...... of complement-mediated attack.
@en
P2093
P2860
P304
16666-16672
P356
10.1074/JBC.M001123200
P407
P577
2000-06-01T00:00:00Z